Prevention of cerebral palsy, autism spectrum disorder, and attention deficit - Hyperactivity disorder

Medical Hypotheses

Volumn 82, Issue 5, 2014, Pages 522-528

  Strickland, Alan D ^a  

^a 101 Waterlily ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; VEGETABLE OIL;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CEREBELLUM; CEREBRAL PALSY; CORPUS CALLOSUM; FETUS (ANATOMY); FIRST TRIMESTER PREGNANCY; FOOD INTAKE; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LEUKOMALACIA; LOW FAT DIET; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANT WOMAN; PROPHYLAXIS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; THEORETICAL MODEL;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CEREBRAL PALSY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; MODELS, THEORETICAL;

EID: 84897107633     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.02.003     Document Type: Article

References (71)

1. Kirby R.S., Wingate M.S., Van Naarden Braun K., et al. Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: a report from the autism and developmental disabilities monitoring network. Res Dev Disabil 2011, 32(2):462-469.
2. Odding E., Roebroeck M.E., Stam H.G. The epidemiology of cerebral palsy: incidence, impairments, and risk factors. Disabil Rehabil 2006, 28(4):183-191.
3. Nelson K.B., Ellenberg J.H. Antecedents of cerebral palsy; multivariate analysis of risk. NEJM 1986, 315(2):81-86.
4. Nelson K.B. Can we prevent cerebral palsy?. NEJM 2003, 349(18):1765-1769.
5. Jacobsson B., Hagberg G. Antenatal risk factors for cerebral palsy. Best Prac Res Clin Obstet Gynaecol 2004, 18(3):426-436.
6. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012, 26(3):383-392.
7. Angelidou A., Asadi S., Alysandratos K., Karagkouni A., Kourembanas S., Theoharides T.C. Perinatal stress, brain inflammation and risk of autism - review and proposal. BMC Pediatr 2012, 12:89-119.
8. Das U.N. Autism as a disorder of deficiency of brain-derived neurotropic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 2013, 29:1175-1185.
9. Glasson E.J., Bower C., Petterson B., de Klerk N., Chaney G., Hallmayer J.F. Perinatal factors and the development of autism. Arch Gen Psychiatry 2004, 61:618-627.
10. Adams L.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011, 11:22-35.
11. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
12. Silva D., Colvin L., Hagemann E., Bower C. Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder. Pediatrics 2014, 133:1-9.
13. Dias M.S., McLon D.G. Normal and abnormal embryology of the nervous system. Pediatric neurosurgery of the developing nervous system 2001, WB Saunders Co., Philadelphia. 4th ed.
14. Human Anatomy: Gray's anatomy on Chapter IX. Neurology. Section 2. Development of the nervous system; 2013 [accessed 17.01.2013]. http://www.theodora.com/anatomy.
15. Human Anatomy: Gray's anatomy on Chapter V. Angiology. Section 3. Development of the vascular system; 2013 [accessed 17.01.2013]. http://www.theodora.com/anatomy.
16. Watchko J.F., Tiribelli C. Bilirubin-induced neurologic damage - mechanisms and management approaches. NEJM 2013, 369:2021-2030.
17. Yao L., Kan E.M., Kaur C., et al. Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitro. PLoS One 2013, 8(11):e78439.
18. Raybaud C. Normal and abnormal embryology and development of the intracranial vascular system. Neurosurg Clin N Am 2010, 21:399-426.
19. Marinkovic S.V., Milisavljevic M.M., Kovacevic M.S., Stevic Z.D. Perforating branches of the middle cerebral artery. Microanatomy and clinical significance of their intracerebral segments. Stroke 1985, 16:1022-1029.
20. Schmahmann J.D. Vascular syndromes of the thalamus. Stroke 2003, 34:2264-2278.
21. Bogousslavsky J., Van Melle G., Regli F. The lausanne stroke registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988, 19:1083-1092.
22. Verney C., Monier A., Fallet-Bianco C., Gressens P. Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants. J Anat 2010, 217:436-448.
23. Rezaie P., Dean A., Male D., Ulfig N. Microglia in the cerebral wall of the human telencephalon at second trimester. Cereb Cortex 2005, 15:938-949.
24. Billards S.S., Haynes R.L., Folkerth R.D., et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 2006, 497(2):199-208.
25. Folkerth R.D. Neuropathologic substrate of cerebral palsy. J Child Neurol 2005, 20(12):940-949.
26. Cunningham C.L., Martinez-Cerdeno V., Noctor S.C. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 2013, 33:4216-4233.
27. Roumier A., Pascual O., Bechade C., et al. Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS One 2008, 3(7):e2595.
28. Xu G., Broadbelt K.G., Haynes R.L., et al. Late development of the GABAergic system in the human cerebral cortex and white matter. J Neuropath Exp Neurol 2011, 70(10):841-858.
29. Bax M., Tydeman C., Flodmark O. Clinical and MRI correlates of cerebral palsy. JAMA 2006, 296(13):1602-1608.
30. Lin J. The cerebral palsies: a physiological approach. J Neurol Neurosurg Psychiatry 2003, 74(Supp. 1):i23-i29.
31. Developmental disabilities in infancy and childhood 2001, vol. 2. Brookes Publishing, Baltimore, MD. 2nd ed.
32. Folkerth R.D. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol 2006, 9(1):3-13.
33. Stolp H.B., Dziegielewska K.M. Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 2009, 35(2):132-146.
34. Shen M.D., Nordahl C.W., Young G.S., et al. Early brain enlargement and elevated extra-axial fluid in infants who develop autism spectrum disorder. Brain 2013, 136(9):2825-2835.
35. McAlonan G.M., Cheung V., Cheung C., et al. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 2005, 128(2):268-276.
36. Morgan J.T., Chana G., Abramson I., Semendeferi K., Courchesne E., Everall I.P. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 2012, 1456:72-81.
37. Rodriguez J.I., Kern J.K. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol 2012, 10.1017/S1740925X12000142, 1-9.
38. Mueller S., Keeser D., Samson A.C., et al. Convergent findings of altered functional and structural brain connectivity in individuals with high functioning autism: a multimodal MRI study. PLoS One 2013, 8(6):e67329.
39. You X., Norr M., Murphy E., et al. Atypical modulation of distant functional connectivity by cognitive state in children with autism spectrum disorders. Front Hum Neurosci 2013, 7:1-13.
40. Chhor V., Schang A.L., Favrais G., Fleiss B., Gressens P. Long-term cerebral effects of perinatal inflammation. Arch Pediatr 2012, 19(9):946-952.
41. Castellanos F.X., Giedd J.N., Eckburg P., et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994, 151(12):1791-1796.
42. Castellanos F.X., Sharp W.S., Gottesman R.F., Greenstein D.K., Giedd J.N., Rapoport J.L. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am J Psychiatry 2003, 160(9):1693-1696.
43. Schneider M., Retz W., Coogan A., Thome J., Rosler M. Anatomical and functional brain imaging in adult attention deficit/hyperactivity disorder (ADHD) - a neurological view. Eur Arch Psychiatry Clin Neurosci 2006, 256(Suppl. 1):i32-i41.
44. Silk T.J., Vance A., Rinehart N., Bradshaw J.L., Cunnington R. White matter abnormalities in attention deficit hyperactivity disorder: a diffusion tensor imaging study. Hum Brain Mapp 2009, 30(9):2757-2765.
45. Emond V., Joyal C., Poissant H. Structural and functional neuroanatomy of attention deficit hyperactivity disorder (ADHD). Encephale 2009, 35(2):107-114.
46. Cherkasova M.V., Hechtman L. Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychaitry 2009, 54(10):651-664.
47. Bilenberg N., Hougaard D., Norgaard-Pedersen B., Nordenbaek C.M., Olsen J. Twin study on transplacental-acquired antibodies and attention deficit-hyperactivity disorder - a pilot study. J Neuroimmunol 2011, 236(1-2):72-75.
48. Blomgren K., Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 2006, 40(3):388-397.
49. Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 2007, 282(26):18661-18665.
50. Kim H.Y., Sawazaki S., Salem N. Lipoxygenation in rat brain?. Biochem Biophys Res Commun 1991, 174(2):729-734.
51. Li B., Birdwell C., Whelan J. Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. J Lipid Res 1994, 35:1869-1877.
52. US Department of Agriculture data files. Dietary intake of vitamin E, linolenic acid, and alpha-linolenic acid. NHANES 2001-2002 [accessed]. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/nhanes01_02.htm.
53. Simopoulos A.P. Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. Eur Heart J Suppl 2001, 3(Suppl. D):D8-D21.
54. Svennerholm L., Vanier M.T. The distribution of lipids in the human nervous system. 3. Fatty acid composition of phosphoglycerides of human foetal and infant brain. Brain Res 1973, 50(2):341-351.
55. Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 1968, 9:570-579.
56. Bas O., Songur A., Sahin O., et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in the rat hippocampus. Neurochem Int 2007, 50(3):548-554.
57. Stolp H.B., Ek C.J., Johansson P.A., Dziegielewska K.M., Bethge N., Wheaton B.J., et al. Factors involved in inflammation-induced developmental white matter damage. Neurosci Lett 2009, 451(3):232-236.
58. Gerstner B., Sifringer M., Dzietko M., et al. Estradiol attenuates hyperoxia induced cell death in the developing white matter. Ann Neurol 2007, 61(6):562-573.
59. Derrick M., Luo N.L., Bregman J.C., et al. Pre-term fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy?. J Neurosci 2004, 24(1):24-34.
60. Derrick M., Drobyshevsky A., Ji X., Tan S. A model of cerebral palsy from fetal hypoxia-ischemia. Stroke 2007, 38:731-735.
61. Burd I., Bentz A.I., Chai J., et al. Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain. J Neurosci Res 2010, 88(9):1872-1881.
62. Elovitz M.A., Brown A.G., Breen K., Anton L., Maubert M., Burd I. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011, 29(6):663-671.
63. Mach M., Dubovicky M., Navarova J., Brucknerova I., Ujhazy E. Experimental modeling of hypoxia in pregnancy and early postnatal life. Interdisc Toxicol 2009, 2:28-32.
64. Derrick M., Drobyshevsky A., Ji X., et al. Hypoxia-ischemia causes persistent movement deficits in a perinatal rabbit model of cerebral palsy: assessed by a new swim test. Int J Dev Neurosci 2009, 27(6):549-557.
65. Beloosesky R., Ginsberg Y., Khatib N., et al. Prophylactic maternal N-acetylcysteine in rats prevents maternal inflammation-induced offspring cerebral injury shown on magnetic resonance imaging. Am J Obstet Gynecol 2013, 208(3):e1-e6. 213.
66. Wojcicki J.M., Heyman M.B. Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. J Matern Fetal Neonatal Med 2011, 24(5):680-686.
67. Roxane Laboratories, Inc. Acetylcysteine package insert. Revised March 2007.
68. Watanabe K., Hamada F., Wakatsuki A., et al. Prophylactic administration of melatonin to the mother throughout pregnancy can protect against oxidative cerebral damage in neonatal rats. J Matern Fetal Neonatal Med 2012, 25(8):1254-1259.
69. Hamada F., Watanabe K., Wakasuki A., et al. Therapeutic effects of maternal melatonin administration on ischemia/reperfusion induced oxidative cerebral damage in neonatal rats. Neonatology 2010, 98:33-40.
70. Lante F., Meunier J., Guiramand J., et al. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 2008, 18(6):602-609.
71. Yavin E., Glozman S., Green P. Docosahexaenoic acid accumulation in the prenatal brain: prooxidant and antioxidant features. J Mol Neurosci 2001, 16:229-235.